Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
Intervention1: Lignocaine infusion: Dose-50mcg/kg/min for 1st hr
25mcg/kg/min for 2nd hr
12mcg/kg/min for next 22hrs
Duration-24 hrs
Route-Intravenous
Intervention2: Nil: Nil
Control Intervention1: Fe
Sponsors
Dr Rajasree O
Eligibility
Inclusion criteria
Inclusion criteria: 1) ASA class I and II undergoing robotic and laparoscopic gynaecologic and urologic oncosurgeries under GA 2) Patients who receive intravenous lignocaine infusion as perioperative analgesic
Exclusion criteria
Exclusion criteria: 1)Known allergy to lignocaine 2)Intraoperative conversion from minimally invasive to laparotomies 3)Patients with hepatic,renal dysfunction, severe cardiac disease and seizure disorders 4)Inability to comprehend NRS or QoR-15 5)Known allergy to paracetamol and NSAIDs 6)Body weight less than 45 kg
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)To assess postoperative pain using nrs 2)To assess quality of recovery using QoR-15 questionnaire 3)To assess incidence of PONV and return of bowel functionTimepoint: 1) for 72hrs postoperatively 2)2nd and 3rd postoperative day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To assess analgesic efficacy of iv lignocaine infusion with another analgesic modality-iv fentanyl 2)Time to discharge from hospital 3) Total opioid consumptionTimepoint: 1) for 72 hours after surgery 3)over 72 hrs postoperatively | — |
Countries
India
Contacts
Public ContactDr Malavika Mohan
Regional Cancer Centre
Outcome results
None listed